Back to state act
Description
On 7 November 2020, the Department of Health and Social Care of the United Kingdom added dabigatran etexilate and semaglutide to the medicines that cannot be parallel exported from the UK. The UK auth...
Sign in to see full description
Intervention Details
Intervention Type
Export ban
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
07 Nov 2020
Revocation date
23 Jun 2022
Implementation level
National
Affected flow
Outward
Announced as temporary
No
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 2 products
Threads
See all
This intervention is not part of any Thread yet.